product summary
Loading...
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
other
product name :
LYNX Rapid APC Antibody Conjugation Kit
catalog :
LNK032APC
quantity :
3 Conjugations For 100µg Antibody
price :
574 USD
more info or order :
citations: 1
Reference
Wielgosz M, Kim Y, Carney G, Zhan J, Reddivari M, Coop T, et al. Generation of a lentiviral vector producer cell clone for human Wiskott-Aldrich syndrome gene therapy. Mol Ther Methods Clin Dev. 2015;2:14063 pubmed publisher
product information
EntityType :
Conjugation Kit
EntityCategory :
Kits
ProductCode :
LNK032APC
Description :
LYNX Rapid APC Antibody Conjugation Kit
Specificity :
APC Conjugation Kit
Format :
Kit
Applications :
CJ
ApplicationTypes :
Conjugation
Quantity :
3 Conjugations For 100µg Antibody
QuantityValue :
3
QuantityType :
Conjugations For 100µg Antibody
EntityFormats :
Kit
UNSPSC :
41116126
NotForSaleInCountries :
KR
PriceGBP :
400
PriceEUR :
559
PriceUSD :
574 USD
PriceCHF :
608
PriceSEK :
6233
PriceNOK :
6429
PriceDKK :
4170
more info or order :
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.